In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy

Circulation

Volumn 91, Issue 12, 1995, Pages 2898-2903

  Goode, Grahame K ^a   Heagerty, Anthony M ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b WITHINGTON HOSPITAL   (United Kingdom)

Author keywords

arteries; blood pressure; endothelium; hypercholesterolemia

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; NITROPRUSSIDE SODIUM;

ADULT; ARTERY DISEASE; ARTERY WALL; ARTICLE; ATHEROMA; BLOOD PRESSURE REGULATION; BLOOD VESSEL FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; IN VITRO STUDY; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL;

EID: 0029006649     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.91.12.2898     Document Type: Article

References (31)

1. Juergens JL, Bernatz PE. Atherosclerosis of the extremities. In: Juergens JL, Spittell JA, Fairbairn JF II, eds. Peripheral Vascular Diseases. Philadelphia, Pa: WB Saunders; 1980:253-293.
2. Zeiher AM, Drexler H, Wollschager H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
3. Creager MA, Cooke JP, Mendlesohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228-234.
4. Lehmann ED, Watts GF, Fatemi-Langroudi B, Gosling RG. Aortic compliance in young patients with heterozygous familial hypercholesterolemia. Clin Sci. 1992;83:717-721.
5. Celermajer DS, Sorensen KE, Gooch UM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Noninvasive defection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
6. Bonaa KH, Thelle DS. Association between blood pressure and serum lipids in a population: the Tromso Study. Circulation. 1991;83:1305-1314.
7. Osborne JA, Lento PH, Siefried MR, Stahl GL, Fusman B, Lefer AM. Cardiovascular effects of acute hypercholesterolemia in rabbits: reversal with lovastatin treatment. J Clin Invest. 1989;83: 465-473.
8. Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest. 1987;80:1808-1811.
9. Leung W-H, Lau C-P, Wong C-K. Beneficial effect of cholesterollowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet. 1993;341:1496-1500.
10. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshia A. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation. 1994;89:2519-2524.
11. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet. 1992;340:1430-1432.
12. Aalkjaer C, Pedersen EB, Danielsen H. Morphological and functional characteristics of isolated resistance vessels in advanced uraemia. Clin Sci. 1986;71:657-663.
13. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19-26.
14. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
15. Cook JP, Andon NA, Girerd XJ, Hirsh AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation. 1991;83:1057-1062.
16. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in the coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 1991;338:1546-1550.
17. Creager MA, Gallagher SJ, Girerd XJ, Colman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90: 1248-1253.
18. Minor RL, Myers PR, Gyerra R, Bates JN, Harrison DG. Dietinduced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 1990;86:2109-2119.
19. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest. 1986;73:1-5.
20. Waldman S, Murad F. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system. J Cardiovasc Pharmacol. 1988;12(suppl 15):5115-5118.
21. Witzaum JL, Steinberg D. Evidence for the presence of oxidatively modified LDL in human atherosclerotic lesions. Circulation. 1989; 80(suppl II):II-160. Abstract.
22. Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction potential mechanism underlying reduction in EDRF/ nitric oxide activity. Circulation. 1992;85:1927-1938.
23. Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest. 1990;86:75-79.
24. Galle J, Öchsle M, Schollmeyer P, Wanner C. Oxidized lipoproteins inhibit endothelium-dependent vasodilation effects of pressure and high density lipoprotein. Hypertension. 1994;23:556-564.
25. Zeiher AM, Schächinger V, Hohnloser SH, Saurbier B, Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Circulation. 1994;89:2525-2532.
26. Stewart DJ, Monge JC. Hyperlipidaemia and endothelial dysfunction. Curr Opin Lipid. 1993;4:319-324.
27. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial Superoxide anion production. J Clin Invest. 1993;91:2546-2551.
28. Raij L, Nagy J, Coffee K, Demaster EC. Hypercholesterolemia promotes endothelial dysfunction in vitamin E- and selenium-deficient rats. Hypertension. 1993;22:56-61.
29. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
30. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
31. Belcher JD, Balla J, Balla G, Jacobs DR Jr, Gross M, Jacob HS, Vercellotti M. Vitamin E, LDL, and endothelium: brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler Thromb. 1993;13:1779-1789.